Home › Funds › BAKER BROS. ADVISORS LP › GPCR
BAKER BROS. ADVISORS LP position in GPCR
STRUCTURE THERAPEUTICS INC · Health Care
BAKER BROS. ADVISORS LP reported holding 1,432,529 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$76.9M, representing 0.40% of its reported portfolio and ranking #30 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed GPCR holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BAKER BROS. ADVISORS LP's GPCR position evolved
BAKER BROS. ADVISORS LP first disclosed a stake in GPCR in Q3 2024 at 85,500 shares (US$3.8M). The position peaked in Q4 2025 at 1,432,529 shares, worth US$99.6M. Across 8 filings, BAKER BROS. ADVISORS LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,432,529 shares valued at US$76.9M. Notable position changes include a 323% increase in Q4 2024 (shares fell 36% over the following quarter), a 594% increase in Q2 2025 (shares rose 35% over the following quarter), a 38% trim in Q3 2025 (shares rose 148% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 85.50K | $3.75M | New |
| Q4 2024 | 361.56K | $9.81M | Add |
| Q1 2025 | 361.56K | $6.26M | Hold |
| Q2 2025 | 2.51M | $52.03M | Add |
| Q3 2025 | 1.56M | $43.57M | Reduce |
| Q4 2025 | 1.43M | $99.63M | Reduce |
| Q1 2026 | 1.43M | $69.05M | Hold |
| Q2 2026 | 1.43M | $76.88M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GPCR and 13F data
GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), BVF INC/IL (US$180.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GPCR
- Avoro Capital Advisors LLC 6.56M sh · $351.84M · Q2 2026
- Deep Track Capital, LP 4.74M sh · $254.40M · Q2 2026
- BVF INC/IL 3.37M sh · $180.70M · Q2 2026
- ORBIMED ADVISORS LLC 2.21M sh · $118.58M · Q2 2026
- RTW INVESTMENTS, LP 1.61M sh · $86.27M · Q2 2026
- Casdin Capital 1.18M sh · $63.06M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.09M sh · $58.29M · Q2 2026
- Siren, L.L.C. 872.97K sh · $46.85M · Q2 2026
- PACIFIC HEIGHTS ASSET MANAGEMENT LLC 800.00K sh · $42.94M · Q2 2026
- Rock Springs Capital Management LP 640.32K sh · $34.37M · Q2 2026
- Logos Global Management LP 500.00K sh · $26.84M · Q2 2026
- Parkman Healthcare Partners LLC 485.66K sh · $26.07M · Q2 2026
More on BAKER BROS. ADVISORS LP
FAQ
How long has BAKER BROS. ADVISORS LP held GPCR?
BAKER BROS. ADVISORS LP has disclosed GPCR holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is BAKER BROS. ADVISORS LP's current position in GPCR?
As of Q2 2026, BAKER BROS. ADVISORS LP holds 1.43M shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $76.88M, representing 0.40% of its reported portfolio and ranking #30.
Has BAKER BROS. ADVISORS LP been buying or selling GPCR?
In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP held unchanged its position in GPCR. The position peaked in Q4 2025 at 1.43M shares.
Which other funds hold GPCR?
Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, BVF INC/IL, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.